Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02034916
Brief Title: A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study) (ABRAZO)

First Submitted : January 9, 2014
First Submitted that Met QC Criteria : January 10, 2014
First Posted : January 14, 2014 (Estimate)

Results First Submitted : September 1, 2017
Results First Submitted that Met QC Criteria : October 6, 2017
Results First Posted : November 6, 2017

Last Update Submitted that Met QC Criteria : July 19, 2019
Last Update Posted : July 31, 2019